Global Bio-Tech Company Saves $2.6M & Reduces Downtime by 90%
FACTS AT A GLANCE
BioTech (Genetic Testing & Digital Health)
Read how this global bio-tech company remains compliant with strict regulations using Aiden’s automation.
Downtime is a costly issue for any business, and for companies in biotech and healthcare, that cost can also be counted in human lives. But minimizing downtime is incredibly challenging as fixing issues requires compliance with numerous HIPAA, HITRUST, and FDA regulatory obligations. At this leading biotech firm that performs genetic testing to diagnose more patients correctly, earlier, and bring therapies to market faster, downtime to address software vulnerabilities or lab equipment failures could mean delaying the processing and production of vital patient test results impacting patient revenue, and growth.
Download this case study to understand why organizations in highly-regulated industries use Aiden.